methylprednisolone hemisuccinate has been researched along with glucose, (beta-d)-isomer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lamche, H; Paul, E; Redl, H; Schiesser, A; Schlag, G | 1 |
| Mata, R; Muniain, MA; Pérez, JJ; Pozuelo, F; Rodríguez, MC; Rodríguez, MD; Romero, A | 1 |
| Packard, BD; Weiler, JM | 1 |
3 other study(ies) available for methylprednisolone hemisuccinate and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
Effect of methylprednisolone, prednisolone and dexamethasone on granulocyte function and complement activation.
Topics: Complement Activation; Complement C3; Complement C3a; Dexamethasone; Endotoxins; Escherichia coli; Glucocorticoids; Granulocytes; Humans; Methylprednisolone Hemisuccinate; Prednisolone; Zymosan | 1987 |
[Effect of corticosteroids, quinacrine and L-652, 731 on experimental aggregation of polymorphonuclear leukocytes induced by complement and platelet activating factor (PAF)].
Topics: Agranulocytosis; Animals; Cell Aggregation; Complement System Proteins; Furans; Methylprednisolone; Methylprednisolone Hemisuccinate; Neutropenia; Platelet Activating Factor; Quinacrine; Rabbits; Zymosan | 1988 |
Methylprednisolone inhibits the alternative and amplification pathways of complement.
Topics: Complement Activation; Complement C3b; Complement Factor B; Complement Factor D; Complement Pathway, Alternative; Enzyme Precursors; Humans; Lipopolysaccharides; Methylprednisolone; Methylprednisolone Hemisuccinate; Zymosan | 1982 |